HOME >> BIOLOGY >> NEWS
Australian wins prestigious prize in biodiversity informatics

The 2007 Ebbe Nielsen Prize has been awarded to Paul Flemons of the Australian Museum, Sydney. The Global Biodiversity Information Facility (GBIF) established the Prize in honor of Dr. Ebbe Schmidt Nielsen, who was an inspirational leader in the fields of biosystematics and biodiversity informatics. This is the only Prize in the world that is given in the area of biodiversity informatics.

The yearly award of 30,000 recognizes a researcher who is combining biosystematics and biodiversity informatics research in an exciting and novel way. Speaking about the Prize when he was notified, Flemons said "I am honoured by the award. GBIF is making a significant contribution to biodiversity informatics."

Paul Flemons applies computer-based ecological modeling to help identify places where lots of species occur together, or species that occur only in very restricted geographical areas. This helps biodiversity scientists be more efficient in their efforts to discover and conserve species.

The GBIF Science Committee noted when it announced the 2007 Prizewinner, Paul Flemons has been a key figure in developing a robust and accessible biodiversity data infrastructure that supports visualization and analysis for use in conservation planning and natural resource decision-making."

Further, the Committee said, "As a software developer, Flemons is particularly attuned to user needs. His work includes innovations that similar developments lack, and he has a rare mix of skill sets." The Prize winner also works on making desktop software tools into web-based tools that can be shared across the Internet. Sharing analytical software in this way promotes collaboration and cooperation among scientists and between scientists and policy-making agencies.

Flemons understands the importance of the interplay between natural history collections data, visualization and analysis tools, and conservation decision-making. He has published in top-tier scient
'"/>

Contact: Meredith A. Lane
mlane@gbif.org
453-532-1484
Global Biodiversity Information Facility
12-Jun-2007


Page: 1 2

Related biology news :

1. West Australian women: Drinking before, and during, pregnancy
2. West Australian fossil find rewrites land mammal evolution
3. A*STAR and the Australian National University establish immunology research collaboration
4. Australian of the Year wins top American honour
5. Diabetes hits 275 Australians each day as pandemic spreads
6. UCSD forms stem cell collaboration with major Australian centers
7. Australian geneticist receives top award
8. Westmead leads Australian bird flu research
9. Australian biomedical scientist wins top UK award for ovary research
10. Australian scientists awarded $1m research fellowships
11. Australian-first cancer research facility opens at UQ

Post Your Comments:
(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
(Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
(Date:7/2/2015)... TN (PRWEB) , ... July 02, 2015 , ... ... the development and manufacturing of surgical instruments in Orthopedics, announced today the acquisition ... contract-manufacturing and the world's largest provider of surgical instruments to the Spine Industry. ...
(Date:7/1/2015)... and PARIS , July ... and Genective, key developer of biotech crops, today ... of new generations of insect control traits. ... to counter the realities of advancing insect resistance. ... AgBiome,s unique insect control technology with Genective,s capability ...
(Date:7/1/2015)... ... 2015 , ... The next-generation sequencing (NGS) clinical market is poised for huge ... industry. BCC Research reveals in its new report that the market drivers of this ... growing need for better diagnostics as part of a molecular diagnostics trend. , The ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
Cached News: